2010
DOI: 10.1590/s1984-82502010000300014
|View full text |Cite
|
Sign up to set email alerts
|

Determination of carbamazepine in pharmaceutical formulations

Abstract: The aim of this study was to evaluate the quality of five different solid formulations of carbamazepine. The reference formulation was Tegretol® 200.00 mg (Novartis) and the others were: generic formulation of carbamazepine 200.00 mg (National Industry), similar formulation of carbamazepine 200.00 mg (National Industry), and two formulations of carbamazepine 200.00 mg acquired from two different compounding pharmacies. The latter consisted of capsules obtained in Natal, the capital city of the Brazilian State … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 8 publications
(11 reference statements)
0
4
0
Order By: Relevance
“…Evaluation of the hydration and dehydration behavior of pharmaceutical substances is important for the development of stable formulations, because the anhydrous and hydrated forms of a drug can show differences in their physicochemical characteristics. Properties including heat capacity, density, crystal structure, chemical stability, hygroscopicity, powder flow, and dissolution rate ultimately affect the bioavailability of a drug (Solon et al, 2010;Ono et al, 2002;McMahon et al, 1996;Qu, Louhi-Kultanen, Kallas, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Evaluation of the hydration and dehydration behavior of pharmaceutical substances is important for the development of stable formulations, because the anhydrous and hydrated forms of a drug can show differences in their physicochemical characteristics. Properties including heat capacity, density, crystal structure, chemical stability, hygroscopicity, powder flow, and dissolution rate ultimately affect the bioavailability of a drug (Solon et al, 2010;Ono et al, 2002;McMahon et al, 1996;Qu, Louhi-Kultanen, Kallas, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…The contents of Brand A, an innovator brand, conformed to the standard (BP 2002) while that of Brands B and C did not conform (Table 4). Bioavailability is the fraction of the administered drug which reaches the blood stream from the gastrointestinal tract (Solon et al, 2010). Thus, the amount of the active ingredient presence in a drug is one of the determinants of bioavailabilty.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it imposes a large economic burden on global health care systems and is a major public health problem in low and middle-income countries (Mbuba and Newton, 2009). Carbamazepine is used in the treatment of trigeminal and glossopharyngeal nerve neuralgia, acting by reducing repetitive activation of the action potential (Solon et al, 2010). It is considered one of the best anticonvulsant, producing less psychological alterations and behavior effects (Castro et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation